Cocrystal Pharma, Inc. (COCP) › Net IncomeCocrystal Pharma, Inc. (COCP) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$319.8K2011: -$5.46M2012: -$7.96M2013: -$3.89M2014: -$99.0K2015: -$50.12M2016: -$74.87M2017: -$613.0K2018: -$49.05M2019: -$48.17M2020: -$9.65M2021: -$14.19M2022: -$38.84M2023: -$17.98M2024: -$17.50M2025: -$8.83M-$8.83M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$8.83M+49.5%2024-$17.50M+2.7%2023-$17.98M+53.7%2022-$38.84M-173.8%2021-$14.19M-47.0%2020-$9.65M+80.0%2019-$48.17M+1.8%2018-$49.05M-7901.3%2017-$613.0K+99.2%2016-$74.87M-49.4%2015-$50.12M-50528.3%2014-$99.0K+97.5%2013-$3.89M+51.2%2012-$7.96M-45.9%2011-$5.46M-1606.4%2010-$319.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share